Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,716 | -67,354 | -44,278 | -19,754 | -57,892 |
| Depreciation Amortization | 7,295 | 5,441 | 3,668 | 1,834 | 7,922 |
| Accounts receivable | 7,551 | 7,003 | 2,458 | -1,350 | -3,968 |
| Other Working Capital | 33,597 | 25,732 | 19,044 | 4,285 | 22,200 |
| Other Operating Activity | 30,019 | 21,027 | 15,116 | 11,992 | 25,337 |
| Operating Cash Flow | $-13,254 | $-8,151 | $-3,992 | $-2,993 | $-6,401 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -161 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,500 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 2,175 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $514 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 18,622 |
| Debt Issued | 10,000 | 9,098 | 891 | N/A | N/A |
| Debt Repayment | -5,900 | -6,969 | -221 | N/A | N/A |
| Common Stock Issued | 12,415 | 5,603 | 3,470 | 2,460 | 58 |
| Other Financing Activity | 2,134 | -303 | -189 | -140 | -11,979 |
| Financing Cash Flow | $18,649 | $7,429 | $3,951 | $2,320 | $6,701 |
| Beginning Cash Position | 10,977 | 10,977 | 10,977 | 10,977 | 10,163 |
| End Cash Position | 16,372 | 10,255 | 10,936 | 10,304 | 10,977 |
| Net Cash Flow | $5,395 | $-722 | $-41 | $-673 | $814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,254 | -8,151 | -3,992 | -2,993 | -6,401 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -161 |
| Free Cash Flow | -13,254 | -8,151 | -3,992 | -2,993 | -6,562 |